Alpha DNA Investment Management’s Cullen/Frost Bankers CFR Stock Holding History

Alpha DNA Investment Management’s Portfolio CFR Stock Details CFR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,738	Closed	-$905K	–	42
2024 Q4	$905K	Buy	6,738 +416	+7%	+$54.6K	0.34%	58
2024 Q3	$707K	Buy	6,322 +766	+14%	+$83.8K	0.26%	91
2024 Q2	$565K	Sell	5,556 -3,450	-38%	-$361K	0.22%	88
2024 Q1	$1.01M	Buy	+9,006	New	+$963K	0.37%	47
2023 Q1	–	Sell	-7,869	Closed	-$1.05M	–	159
2022 Q4	$1.05M	Buy	7,869 +3,433	+77%	+$488K	0.37%	108
2022 Q3	$586K	Sell	4,436 -4,358	-50%	-$571K	0.49%	84
2022 Q2	$1.02M	Buy	+8,794	New	+$1.12M	0.87%	45

Other funds holding CFR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha DNA Investment Management's CFR Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Cullen/Frost Bankers (CFR) in Q1 2025, closing a stake of 6,738 shares — an estimated $905K sold.

Alpha DNA Investment Management first reported a position in CFR in Q2 2022 and held it in 7 quarters. The position peaked at $1.05M in Q4 2022. 480 funds tracked by Wall St. Rank hold CFR as of Q1 2025.

Alpha DNA Investment Management reported no remaining Cullen/Frost Bankers position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 6,738 Cullen/Frost Bankers shares in Q1 2025, an estimated $905K.
Alpha DNA Investment Management first reported a position in Cullen/Frost Bankers in Q2 2022 and held it in 7 quarters.
Alpha DNA Investment Management's Cullen/Frost Bankers position peaked at $1.05M in Q4 2022.
480 funds tracked by Wall St. Rank held Cullen/Frost Bankers as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.